BOONE CAPITAL MANAGEMENT LLC
13F Reported Value
ⓘ$427.5M
Holdings
16
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
BOONE CAPITAL MANAGEMENT LLC disclosed 16 positions worth $427.5M in its Form 13F-HR for Q2 2026, led by $TFX (TELEFLEX INC) at 11.5% of the equity portfolio, followed by $MIRM and $CI. During the quarter the fund opened 7 new positions and exited 4 — including a new stake in $VSTS and a full exit from $MDT. The portfolio is most concentrated in Healthcare (93.5% of disclosed assets). All figures are sourced directly from BOONE CAPITAL MANAGEMENT LLC’s Form 13F-HR filing with the SEC under CIK 1882053.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 37.5#2,231
Quality
$49.1M387,388 sh - 35.0#2,321
Quality
$48.7M415,641 sh - 66.2#432
Quality
$43.9M159,290 sh - 23.4
Quality
$41.2M519,977 sh - 62.7
Quality
$36.9M88,687 sh - 58.2
Quality
$33.4M583,219 sh - 62.3
Quality
$29.8M711,939 sh - 45.3
Quality
$27.6M1,900,140 sh - 36.9
Quality
$25.3M339,720 sh - 62.6
Quality
$19.1M515,818 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 TELEFLEX INC$TFX | 37.5#2,231 | $49.1M | 387,388 |
 Mirum Pharmaceuticals, Inc.$MIRM | 35.0#2,321 | $48.7M | 415,641 |
 Cigna Group$CI | 66.2#432 | $43.9M | 159,290 |
 IONIS PHARMACEUTICALS INC$IONS | 23.4 | $41.2M | 519,977 |
 UNITEDHEALTH GROUP INC$UNH | 62.7 | $36.9M | 88,687 |
 BIOMARIN PHARMACEUTICAL INC$BMRN | 58.2 | $33.4M | 583,219 |
 Guardian Pharmacy Services, Inc.$GRDN | 62.3 | $29.8M | 711,939 |
 Vestis Corp$VSTS | 45.3 | $27.6M | 1,900,140 |
 BridgeBio Pharma, Inc.$BBIO | 36.9 | $25.3M | 339,720 |
 Pennant Group, Inc.$PNTG | 62.6 | $19.1M | 515,818 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of BOONE CAPITAL MANAGEMENT LLC's 16 positions.
Showing top 10 of 16 holdings.
Sector Allocation
Healthcare
$399.9M
Consumer Staples
$27.6M
Full Holdings — BOONE CAPITAL MANAGEMENT LLC (Q2 2026)
All 16 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $TFX | TELEFLEX INC | $49.1M | 11.5% | +39% | 37.5 |
| 2 | $MIRM | Mirum Pharmaceuticals, Inc. | $48.7M | 11.4% | -1% | 35 |
| 3 | $CI | Cigna Group | $43.9M | 10.3% | +16% | 66.2 |
| 4 | $IONS | IONIS PHARMACEUTICALS INC | $41.2M | 9.6% | +4% | 23.4 |
| 5 | $UNH | UNITEDHEALTH GROUP INC | $36.9M | 8.6% | +12% | 62.7 |
| 6 | $BMRN | BIOMARIN PHARMACEUTICAL INC | $33.4M | 7.8% | +6% | 58.2 |
| 7 | $GRDN | Guardian Pharmacy Services, Inc. | $29.8M | 7.0% | +13% | 62.3 |
| 8 | $VSTS | Vestis Corp | $27.6M | 6.5% | NEW | 45.3 |
| 9 | $BBIO | BridgeBio Pharma, Inc. | $25.3M | 5.9% | +48% | 36.9 |
| 10 | $PNTG | Pennant Group, Inc. | $19.1M | 4.5% | NEW | 62.6 |
| 11 |  $GLUE | Monte Rosa Therapeutics, Inc. | $14.9M | 3.5% | NEW | 30.3 |
| 12 |  $KOD | Kodiak Sciences Inc. | $14.7M | 3.4% | +34% | — |
| 13 |  $TNGX | Tango Therapeutics, Inc. | $14.2M | 3.3% | NEW | 17.6 |
| 14 |  $KYMR | Kymera Therapeutics, Inc. | $13.0M | 3.0% | NEW | 28.4 |
| 15 |  $CGEM | Cullinan Therapeutics, Inc. | $12.8M | 3.0% | NEW | — |
| 16 |  $ANL | Adlai Nortye Group Ltd. | $3.0M | 0.7% | NEW | — |
New Positions (7)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for BOONE CAPITAL MANAGEMENT LLC including:
Track BOONE CAPITAL MANAGEMENT LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for BOONE CAPITAL MANAGEMENT LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: BOONE CAPITAL MANAGEMENT LLC
13F Pro is an AI hedge fund tracker and stock research platform. For BOONE CAPITAL MANAGEMENT LLC (SEC CIK: 1882053), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in BOONE CAPITAL MANAGEMENT LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.